About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
448
By Phase
NA: 1PHASE2: 4PHASE1: 1PHASE3: 1
By Status
COMPLETED: 7
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06738199Collaborator
Glycoprotein Matrix-Bound Iron Improves Iron Absorption
NACompleted
17 participants
Started: Feb 1, 2024 · Completed: Apr 22, 2024
NCT04784897Lead Sponsor
A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19
PHASE2Completed
120 participants
Started: Feb 22, 2021 · Completed: Jul 30, 2021
NCT04240223Lead Sponsor
A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers
PHASE1Completed
9 participants
Started: Jan 6, 2020 · Completed: Feb 12, 2020
NCT03042702Lead Sponsor
A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer
PHASE2Completed
2 participants
Started: Feb 9, 2017 · Completed: Nov 10, 2017
NCT02949388Lead Sponsor
Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
PHASE2Completed
199 participants
Started: Nov 30, 2016 · Completed: Dec 31, 2017
Locations (1)
Headquarters
Wakefield, MA, United States
Map
Loading map...